Warning: The NCBI web site requires JavaScript to function. more...
Lessons from animal models of arthritis over the past decade.
van den Berg WB.
Arthritis Res Ther. 2009;11(5):250. Epub 2009 Oct 14. Review.
Related citations
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
Arthritis Rheum. 2006 Aug;54(8):2423-33.
Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, Takeda K, Akira S, Lubberts E, van de Loo FA, van den Berg WB.
J Immunol. 2003 Dec 1;171(11):6145-53.
GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP, Mus AM, de Bruijn MJ, de Vogel L, Boon L, Cornelissen F, Asmawidjaja P, Hendriks RW, Lubberts E.
Arthritis Rheum. 2009 Mar;60(3):750-9.
Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation.
Berlo SE, van Kooten PJ, Ten Brink CB, Hauet-Broere F, Oosterwegel MA, Glant TT, Van Eden W, Broeren CP.
J Autoimmun. 2005 Nov;25(3):172-80. Epub 2005 Oct 27.
IL-27 induces a Th1 immune response and susceptibility to experimental arthritis.
Cao Y, Doodes PD, Glant TT, Finnegan A.
J Immunol. 2008 Jan 15;180(2):922-30.
The genetic and immunopathological processes underlying collagen-induced arthritis.
Luross JA, Williams NA.
Immunology. 2001 Aug;103(4):407-16. Review.
Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL, Van De Loo FA, Holthuysen AE, Van Den Bersselaar LA, Vermeer H, Van Den Berg WB.
J Rheumatol. 1995 Dec;22(12):2250-8.
Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2R beta/IL-4R alpha chimeric cytokine receptor transgene.
Chen Y, Rosloniec E, Goral MI, Boothby M, Chen J.
J Immunol. 2001 Mar 15;166(6):4163-9.
The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
Lubberts E, Koenders MI, van den Berg WB.
Arthritis Res Ther. 2005;7(1):29-37. Epub 2004 Nov 30. Review.
Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Kolls JK, Joosten LA, van den Berg WB.
Arthritis Rheum. 2005 Mar;52(3):975-83.
Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL, Grevers L, Lubberts E, de Vries TJ, Nabbe KC, Verbeek S, Oppers B, Sloetjes A, Blom AB, van den Berg WB.
Arthritis Rheum. 2006 Dec;54(12):3868-77.
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.
Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, Gravallese E, Mathis D, Benoist C.
J Exp Med. 2002 Jul 1;196(1):77-85.
Pathological role of osteoclast costimulation in arthritis-induced bone loss.
Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H.
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11394-9. Epub 2007 Jun 25.
Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.
Ferrari-Lacraz S, Zanelli E, Neuberg M, Donskoy E, Kim YS, Zheng XX, Hancock WW, Maslinski W, Li XC, Strom TB, Moll T.
J Immunol. 2004 Nov 1;173(9):5818-26.
T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA, Abdollahi-Roodsaz S, Heuvelmans-Jacobs M, Helsen MM, van den Bersselaar LA, Oppers-Walgreen B, Koenders MI, van den Berg WB.
Arthritis Rheum. 2008 Jan;58(1):98-108.
Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice.
Niki Y, Yamada H, Kikuchi T, Toyama Y, Matsumoto H, Fujikawa K, Tada N.
J Immunol. 2004 Jan 1;172(1):577-84.
Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S.
J Clin Invest. 2004 Aug;114(4):582-8.
Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.
Arthritis Rheum. 2005 Oct;52(10):3239-47.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on